A comprehensive analysis method is utilized to detect the presence of a wide array of substances within a biological sample. This particular screening process is designed to identify metabolites related to numerous prescription medications, illicit drugs, and synthetic compounds. For example, such a procedure could reveal the use of opioids, benzodiazepines, amphetamines, cocaine, marijuana, barbiturates, methadone, and other commonly abused substances, along with newer synthetic drugs and prescription medications.
The implementation of such extensive screening offers several advantages. It can provide a more complete picture of an individual’s substance use than less comprehensive methods. This enhanced detection capability is valuable in various settings, including workplace safety programs, clinical monitoring for medication adherence, and substance abuse treatment programs. Historically, simpler screening methods were limited in scope, leading to the potential for missed detection of certain substances, particularly with the rise of novel synthetic drugs.